Bioceres Crop Solutions Corp (BIOX) Fair Value & Analysis
Basic Materials · US · Market cap $23.8M
Bioceres Crop Solutions Corp
BIOX · US
Fair value as of: Jul 15, 2026
From 10 valuation models · updated today
Fair value updated Jul 15, 2026 — revised from $12.35 to $0.4300 (−96.5%) since Jun 24, 2026. Share price −16.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.3251 – $4.42 · fair‑value band $0.1544 – $0.7056 · the $0.3500 price screens below the $0.4300 fair value. As of Jul 15, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Bioceres Crop Solutions Corp (BIOX) currently trades at $0.3500, while our model-based Fair Value estimate is $0.4300 — implying the stock looks roughly 22.9% undervalued today. We read business quality at 21/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Bioceres Crop Solutions Corp generated revenue of $255M at a net margin of -96.9%. Revenue declined 35.9% year over year. It earns a return on equity of -32.2%. Net debt stands at $244M. Fundamentals as of Jul 15, 2026
Our scenario range runs from $0.1544 (bear case) to $0.7056 (bull case); at $0.3500, the current price sits within that range. For context, the median of 10 Basic Materials peers we cover trades at 24% fair-value upside — at 23%, BIOX screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 15, 2026. TTM = trailing twelve months.
About the company
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bioceres Crop Solutions Corp reported revenue of $333M in FY2025 versus $207M in FY2021, a compound +12.7%/yr. Reported net income was −$51.8M in FY2025.
Is BIOX fairly valued? → Check now
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $77.46 | $39.29 | -49% |
| Nutrien Ltd NTR | $62.25 | $80.29 | +29% |
| Qinghai Salt Lake Industry Co 000792 | ¥29.03 | ¥21.15 | -27% |
| CF Industries Holdings C1FI34 | R$577.43 | R$978.53 | +69% |
| Yara International ASA YAR | kr 502.80 | kr 695.65 | +38% |
| ICL Group ICL | $5.00 | $3.44 | -31% |
| Yunnan Yuntianhua Co 600096 | ¥29.60 | ¥36.70 | +24% |
| The Mosaic Company MOS | $19.82 | $25.47 | +29% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥44.31 | ¥38.01 | -14% |
| Coromandel International Limited COROMANDEL | ₹2,060 | ₹1,129 | -45% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Bioceres Crop Solutions Corp (BIOX) undervalued?
What is the fair value of BIOX?
What is the quality score of BIOX?
What is the revenue of Bioceres Crop Solutions Corp (BIOX)?
What is the net profit margin of BIOX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Bioceres Crop Solutions Corp analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.